|
gptkbp:instance_of
|
gptkb:Cell
|
|
gptkbp:associated_with
|
autoimmune diseases
|
|
gptkbp:enhances
|
T helper 17 cells
|
|
gptkbp:has_role
|
gptkb:Crohn's_disease
gptkb:ulcerative_colitis
psoriasis
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
IL-23
|
|
gptkbp:influences
|
B cell activation
|
|
gptkbp:initiated_by
|
apoptosis of T cells
|
|
gptkbp:interacts_with
|
IL-12
|
|
gptkbp:involved_in
|
gptkb:disease
gptkb:diabetes
gptkb:sickle_cell_disease
gptkb:systemic_lupus_erythematosus
gptkb:Fuchsia
gptkb:rheumatoid_arthritis
gptkb:ankylosing_spondylitis
gptkb:neurodegenerative_diseases
gptkb:multiple_sclerosis
chronic pain
metabolic syndrome
obesity
neuroinflammation
cardiovascular diseases
fungal infections
sepsis
burn injury
fibromyalgia
immune tolerance
inflammatory responses
thrombosis
cancer progression
acute inflammation
chronic inflammation
tissue repair
viral infections
bacterial infections
atopic dermatitis
host defense
trauma response
pathogen response
parasitic infections
chronic rhinosinusitis
allergic asthma
Th17 differentiation
|
|
gptkbp:is_targeted_at
|
biologic therapies
|
|
gptkbp:is_vulnerable_to
|
IL-23 receptor
|
|
gptkbp:produced_by
|
macrophages
dendritic cells
|
|
gptkbp:promotes
|
inflammation
|
|
gptkbp:regulates
|
immune response
|
|
gptkbp:subunit
|
p19
p40
|
|
gptkbp:bfsParent
|
gptkb:guselkumab
gptkb:Guselkumab
gptkb:risankizumab
gptkb:ALX-0681
gptkb:ALX-0691
gptkb:ALX-0693
gptkb:ALX-0694
gptkb:ALX-0696
gptkb:ALX-0697
gptkb:ALX-0699
gptkb:ALX-0703
gptkb:ALX-0704
gptkb:ALX-0715
gptkb:ALX-0719
gptkb:Risankizumab
gptkb:Tildrakizumab
|
|
gptkbp:bfsLayer
|
6
|